VentiRx Pharmaceuticals' Series A - III Round

VentiRx Pharmaceuticals raised a round of funding on September 02, 2014.

VentiRx Pharmaceuticals is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies for the treatment of cance…

Articles about VentiRx Pharmaceuticals' Series A - III Round: